DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 23 filers reported holding DIAMEDICA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $564,597 | -29.3% | 218,778 | +18.3% | 0.00% | – |
Q2 2023 | $798,638 | +182.4% | 184,870 | 0.0% | 0.00% | – |
Q1 2023 | $282,851 | +96766.8% | 184,870 | 0.0% | 0.00% | – |
Q4 2022 | $292 | -99.9% | 184,870 | -0.2% | 0.00% | – |
Q3 2022 | $229,000 | -35.9% | 185,219 | +4.6% | 0.00% | – |
Q2 2022 | $357,000 | -18.3% | 177,022 | +1.2% | 0.00% | – |
Q1 2022 | $437,000 | -30.1% | 174,858 | +4.2% | 0.00% | – |
Q4 2021 | $625,000 | -7.0% | 167,763 | 0.0% | 0.00% | – |
Q3 2021 | $672,000 | +13.1% | 167,763 | +25.6% | 0.00% | – |
Q2 2021 | $594,000 | -49.4% | 133,569 | +4.0% | 0.00% | – |
Q1 2021 | $1,175,000 | +11.8% | 128,468 | +23.9% | 0.00% | – |
Q4 2020 | $1,051,000 | +296.6% | 103,699 | +65.5% | 0.00% | – |
Q3 2020 | $265,000 | -32.1% | 62,662 | +11.1% | 0.00% | – |
Q2 2020 | $390,000 | +142.2% | 56,412 | -1.9% | 0.00% | – |
Q1 2020 | $161,000 | -5.3% | 57,524 | +63.8% | 0.00% | – |
Q4 2019 | $170,000 | +448.4% | 35,114 | +128.0% | 0.00% | – |
Q3 2019 | $31,000 | – | 15,399 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 1,146,470 | $4,861,000 | 5.06% |
Corriente Advisors, LLC | 730,000 | $3,095,000 | 1.57% |
Manatuck Hill Partners, LLC | 571,500 | $2,423,000 | 1.11% |
CVI Holdings, LLC | 276,176 | $1,171,000 | 0.48% |
DAFNA Capital Management LLC | 156,529 | $664,000 | 0.22% |
Worth Venture Partners, LLC | 42,887 | $182,000 | 0.15% |
Granite Point Capital Management, L.P. | 646,855 | $2,743,000 | 0.15% |
Ikarian Capital, LLC | 415,000 | $1,759,000 | 0.13% |
Maven Securities LTD | 359,285 | $1,473,000 | 0.12% |
Nantahala Capital Management | 756,193 | $3,206,000 | 0.10% |